Previously, AqB011-treated mice were used to assess the role of AQP1 in cardiac hypertrophy [100], and 5-PMFC was used at doses up to 2.5 mM in human red blood cells and rodent models of sickle cell disease for anti-sickling effects [29]. Here, AQP1 is linked to sickle cell disease.